Total Payments
$115,615
2024 Payments
$34,702
Companies
59
Transactions
598
Medicare Patients
9,077
Medicare Billing
$1.5M
Payment Breakdown by Category
Other$79,332 (68.6%)
Food & Beverage$16,658 (14.4%)
Consulting$14,210 (12.3%)
Travel$5,308 (4.6%)
Education$106.78 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $58,057 | 31 | 50.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $17,275 | 4 | 14.9% |
| Food and Beverage | $16,658 | 519 | 14.4% |
| Consulting Fee | $14,210 | 11 | 12.3% |
| Travel and Lodging | $5,308 | 26 | 4.6% |
| Honoraria | $4,000 | 2 | 3.5% |
| Education | $106.78 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| IDORSIA PHARMACEUTICALS US INC | $34,701 | 60 | $0 (2024) |
| ZOLL Respicardia, Inc. | $21,941 | 22 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $19,246 | 118 | $0 (2024) |
| Inspire Medical Systems, Inc. | $17,869 | 36 | $0 (2024) |
| EISAI INC. | $9,604 | 26 | $0 (2022) |
| Axsome Therapeutics, Inc. | $2,455 | 18 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $2,373 | 93 | $0 (2024) |
| Fisher & Paykel Healthcare Inc | $1,812 | 4 | $0 (2024) |
| Novo Nordisk Inc | $1,054 | 26 | $0 (2024) |
| Amgen Inc. | $375.16 | 16 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34,702 | 80 | JAZZ PHARMACEUTICALS INC. ($9,657) |
| 2023 | $45,956 | 164 | IDORSIA PHARMACEUTICALS US INC ($23,273) |
| 2022 | $10,674 | 105 | ZOLL Respicardia, Inc. ($2,500) |
| 2021 | $18,040 | 89 | ZOLL Respicardia, Inc. ($10,475) |
| 2020 | $4,080 | 61 | Eisai Inc. ($2,384) |
| 2019 | $852.88 | 36 | Amgen Inc. ($244.21) |
| 2018 | $584.88 | 34 | Amgen Inc. ($91.93) |
| 2017 | $725.75 | 29 | Grifols USA, LLC ($140.01) |
All Payment Transactions
598 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Consulting Fee | Cash or cash equivalent | $2,375.00 | General |
| Category: NEUROLOGY | ||||||
| 12/13/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| Category: NEUROLOGY | ||||||
| 12/13/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Consulting Fee | Cash or cash equivalent | $1,425.00 | General |
| Category: NEUROLOGY | ||||||
| 12/13/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Travel and Lodging | Cash or cash equivalent | $521.30 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | Fisher & Paykel Healthcare Inc | FISHER & PAYKEL HEALTHCARE (Device), FISHER & PAYKEL HEALTHCARE, FISHER & PAYKEL HEALTHCARE | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: Sleep | ||||||
| 12/06/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Neurology | ||||||
| 12/05/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: NEUROLOGY | ||||||
| 12/02/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Insomnia | ||||||
| 12/02/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Travel and Lodging | Cash or cash equivalent | $88.44 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $300.88 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Travel and Lodging | Cash or cash equivalent | $276.28 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $32.57 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Insomnia | ||||||
| 10/23/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $27.52 | General |
| Category: Sleep Apnea testing | ||||||
| 10/17/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $148.28 | General |
| Category: NEUROLOGY | ||||||
| 10/07/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $71.02 | General |
| Category: Insomnia | ||||||
| 10/07/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $66.23 | General |
| Category: Insomnia | ||||||
| 10/07/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $63.00 | General |
| Category: Insomnia | ||||||
| 10/07/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $57.89 | General |
| Category: Insomnia | ||||||
| 10/07/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $28.24 | General |
| Category: Insomnia | ||||||
| 10/02/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,177.50 | General |
| Category: Insomnia | ||||||
| 10/02/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Insomnia | ||||||
| 09/27/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Insomnia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 3,458 | 10,285 | $1.9M | $700,697 |
| 2022 | 12 | 3,345 | 5,723 | $1.5M | $590,817 |
| 2021 | 14 | 1,175 | 1,417 | $400,571 | $139,405 |
| 2020 | 19 | 1,099 | 1,425 | $248,736 | $106,850 |
Total Patients
9,077
Total Services
18,850
Medicare Billing
$1.5M
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 325 | 337 | $396,153 | $149,992 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 964 | 1,564 | $399,085 | $146,605 | 36.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 481 | 3,676 | $350,760 | $135,964 | 38.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 500 | 3,169 | $304,743 | $118,302 | 38.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 108 | 122 | $150,033 | $57,440 | 38.3% |
| 94660 | Therapy procedure using a positive pressure ventilator | Office | 2023 | 264 | 502 | $62,999 | $23,802 | 37.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 172 | 172 | $57,656 | $19,299 | 33.5% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 216 | 228 | $52,636 | $19,107 | 36.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 83 | 126 | $45,066 | $17,508 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 176 | 190 | $34,482 | $8,883 | 25.8% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 138 | 166 | $6,142 | $2,393 | 39.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,941 | $786.75 | 26.8% |
| 95977 | Electronic analysis of implanted neurostimulator generator with complex cranial nerve stimulator programming | Office | 2023 | 18 | 20 | $2,200 | $613.96 | 27.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 392 | 403 | $477,362 | $186,918 | 39.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 645 | 2,306 | $228,294 | $90,523 | 39.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 157 | 173 | $214,370 | $84,274 | 39.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 493 | 780 | $199,888 | $76,571 | 38.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 359 | 359 | $121,394 | $41,545 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 470 | 575 | $104,675 | $40,181 | 38.4% |
| 94660 | Therapy procedure using a positive pressure ventilator | Office | 2022 | 368 | 630 | $80,589 | $31,439 | 39.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 253 | 253 | $57,388 | $17,605 | 30.7% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2022 | 123 | 126 | $38,406 | $13,430 | 35.0% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 36 | 36 | $12,600 | $2,854 | 22.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 20 | $7,261 | $2,756 | 38.0% |
| 95977 | Electronic analysis of implanted neurostimulator generator with complex cranial nerve stimulator programming | Office | 2022 | 31 | 62 | $6,822 | $2,721 | 39.9% |
About Dr. Kunal Agarwal, MD
Dr. Kunal Agarwal, MD is a Sleep Medicine healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2011. The National Provider Identifier (NPI) number assigned to this provider is 1932497773.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kunal Agarwal, MD has received a total of $115,615 in payments from pharmaceutical and medical device companies, with $34,702 received in 2024. These payments were reported across 598 transactions from 59 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($58,057).
As a Medicare-enrolled provider, Agarwal has provided services to 9,077 Medicare beneficiaries, totaling 18,850 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Location Sarasota, FL
- Active Since 07/14/2011
- Last Updated 11/16/2021
- Taxonomy Code 207QS1201X
- Entity Type Individual
- NPI Number 1932497773
Products in Payments
- QUVIVIQ (Drug) $34,701
- remede System (Device) $21,941
- XYWAV (Drug) $18,370
- INSPIRE (Device) $14,953
- Dayvigo (Drug) $9,528
- Inspire Upper Airway Stimulation System (Device) $2,917
- Sunosi (Drug) $2,455
- FISHER & PAYKEL HEALTHCARE (Device) $1,812
- WAKIX (Drug) $1,278
- Wakix (Drug) $1,094
- SUNOSI (Drug) $571.60
- RYBELSUS (Drug) $496.35
- LUMRYZ (Drug) $326.91
- NURTEC ODT (Drug) $284.83
- Wegovy (Drug) $263.25
- HETLIOZ (Drug) $211.09
- UTIBRON NEOHALER (Drug) $201.73
- Ozempic (Drug) $200.24
- WatchPATONE (Device) $170.41
- EndoMAXX Stent and Delivery System (Device) $161.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.